Latest filing published 24 Jun 2026 for BridgeBio Pharma, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -51.6%Entry US$16.29 · Close at T+365 US$7.88
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Andrew Lo: trading record in brief
This profile gathers the share dealings of Andrew Lo across 6 companies, led by Urovant Sciences Ltd., BridgeBio Pharma, Inc. and Sio Gene Therapies Inc. Over a trading history stretching from 2 April 2018 to 22 June 2026, the count stands at 43 filings.
In open-market terms, that means 35 purchases worth €109.7M on one side and 5 sales worth €8.9M on the other. Purchases outweigh sales by €100.9M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 3 share grants.
Half of the purchases are above €50k and half below. Clusters matter here: 34 out of 34 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
On 24 June 2026 came the latest disclosure, a share grant in BridgeBio Pharma, Inc. The clock since the last published purchase (3 January 2022) now reads 1,771 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Andrew Lo
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,990 sharesCommon StockSEC:0001470831-26-000634:0
- 3,798 shares@ US$67.062.5% of flowCommon StockSEC:0001470831-25-000357:1
- 24,007 shares@ US$65.2315.1% of flowCommon StockSEC:0001470831-25-000357:2
- 30,993 shares@ US$66.0519.7% of flowCommon StockSEC:0001470831-25-000357:3
- 36,801 shares@ US$66.626337.8% of flowCommon StockSEC:0001470831-25-000357:0
- 6,589 shares0Common StockSEC:0000950170-25-089674:0
- 100,000 shares@ US$38.49961.0% of flowCommon StockSEC:0000950170-25-064558:0
- 52,142 shares0Common SharesSEC:0001140361-22-033876:0
- 1,500 shares@ US$14.300.2% of flowCommon StockSEC:0000899243-22-000188:1Canonical exit: 30 Mar 2022 (T+90)
- 6,000 shares@ US$12.901.2% of flowCommon StockSEC:0000899243-22-000188:0Canonical exit: 29 Mar 2022 (T+90)
- 86,938 shares@ US$14.02100.0% of flowShare Option (right to buy)SEC:0001209191-21-068291:0Canonical exit: 3 Mar 2022 (T+90)
- 6,706 shares@ US$8.210.1% of flowCommon Shares, par value $0.000037453 per shareSEC:0001104659-19-036418:1Canonical exit: 16 Sept 2019 (T+90)
- 6,541 shares@ US$8.530.1% of flowCommon Shares, par value $0.000037453 per shareSEC:0001104659-19-036418:0Canonical exit: 15 Sept 2019 (T+90)
- 4,957 shares@ US$8.170.1% of flowCommon Shares, par value $0.000037453 per shareSEC:0001104659-19-036418:2Canonical exit: 17 Sept 2019 (T+90)
- 7,500 shares@ US$8.300.2% of flowCommon Shares, par value $0.000037453 per shareSEC:0001104659-19-035736:0Canonical exit: 10 Sept 2019 (T+90)
- 7,367 shares@ US$7.950.2% of flowCommon Shares, par value $0.000037453 per shareSEC:0001104659-19-035736:1Canonical exit: 11 Sept 2019 (T+90)
- 7,144 shares@ US$7.910.1% of flowCommon Shares, par value $0.000037453 per shareSEC:0001104659-19-035736:2Canonical exit: 12 Sept 2019 (T+90)
- 6,649 shares@ US$7.970.1% of flowCommon Shares, par value $0.000037453 per shareSEC:0000919574-19-004081:0Canonical exit: 5 Sept 2019 (T+90)
- 7,500 shares@ US$8.350.2% of flowCommon Shares, par value $0.000037453 per shareSEC:0000919574-19-004081:1Canonical exit: 8 Sept 2019 (T+90)
- 7,189 shares@ US$8.580.2% of flowCommon Shares, par value $0.000037453 per shareSEC:0000919574-19-004081:2Canonical exit: 9 Sept 2019 (T+90)
- 7,500 shares@ US$7.590.2% of flowCommon Shares, par value $0.000037453 per shareSEC:0000919574-19-003994:0Canonical exit: 2 Sept 2019 (T+90)
- 6,540 shares@ US$8.020.1% of flowCommon Shares, par value $0.000037453 per shareSEC:0000919574-19-003994:1Canonical exit: 3 Sept 2019 (T+90)
- 7,082 shares@ US$8.000.1% of flowCommon Shares, par value $0.000037453 per shareSEC:0000919574-19-003994:2Canonical exit: 4 Sept 2019 (T+90)
- 2,424,242 shares@ US$8.2549.3% of flowCommon Shares, $0.000017727 par value per shareSEC:0000919574-19-003993:0Canonical exit: 2 Sept 2019 (T+90)
- 6,951 shares@ US$7.970.1% of flowCommon Shares, par value $0.000037453 per shareSEC:0000919574-19-003949:0Canonical exit: 28 Aug 2019 (T+90)
25 of 11 declarations
